Drug profile · INN
meclizine hydrochloride
MECLIZINE HYDROCHLORIDE
meclizine hydrochloride (MECLIZINE HYDROCHLORIDE) is a histamine h1 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — meclizine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
meclizine hydrochloride (MECLIZINE HYDROCHLORIDE) is a histamine h1 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is meclizine hydrochloride?
meclizine hydrochloride (MECLIZINE HYDROCHLORIDE) is a histamine h1 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for meclizine hydrochloride?
MECLIZINE HYDROCHLORIDE is a marketed brand name for meclizine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of meclizine hydrochloride?
meclizine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.